Papers matching “classifier generalization” 19
Not finding it? Sign in to also search OpenAlex live.
-
Abstract P2-03-13: Breast Cancer Index (BCI) identifies fewer patients with high risk of late recurrence and high likelihood of benefit from extended endocrine therapy with invasive lobular compared to invasive ductal carcinoma2023 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Otto Metzger, Neeta Parimi, Natalia Siuliukina, Yi Zhang, Kai Treuner, Gerrit‐Jan Liefers
3citations -
Abstract PS6-06: The 70-gene signature (MammaPrint) accurately predicts distant breast cancer recurrence risk in patients aged ≥70 years from the population-based observational FOCUS cohort2021 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Iris Noordhoek, Esther Bastiaannet, Ersan Lujinovic, Laura J. Esserman, Jelle Wesseling, Astrid N. Scholten, +7 more
0citations -
Gastrointestinal Bleeding Types and Associated Mortality Rates in Dialysis Patients2023 Journal of the American Society of Nephrology conference-abstract Medicine Gastrointestinal Bleeding Diagnosis and Treatment
Belén Alejos, Yue Jiao, Melanie Wolf, John W. Larkin, Anke C. Winter, Sheetal Chaudhuri, +7 more
0citations -
P0158 Immune profiles of Inflammatory Bowel Disease and Spondyloarthritis call for personalized medicine2025 Journal of Crohn s and Colitis conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Suzanne H. C. Veltkamp, Floris A van Gaalen, J N Samsom, Andrea E. van der Meulen‐de Jong, Philip W. Voorneveld
0citations -
OP0334 VASODILATION REDUCES THE RISK OF NEW ONSET OF INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS: AN ASSOCIATION STUDY FROM THE EUSTAR DATABASE2025 Annals of the Rheumatic Diseases conference-abstract Medicine Systemic Sclerosis and Related Diseases Open access
L. Petelytska, Lorenzo Tofani, E. Siegert, Elisa Zanatta, Gianluca Moroncini, C. Bergmann, +13 more
0citations -
First safety analysis of an open-label, single arm phase II trial investigating the efficacy, safety and quality of life of neoadjuvant chemotherapy with liposomal irinotecan combined with oxaliplatin and 5-fluoruracil/folinic acid followed by curative surgical resection in patients with hepatic oligometastatic adenocarcinoma of the pancreas (HOLIPANC).2025 Journal of Clinical Oncology conference-abstract Medicine Pancreatic and Hepatic Oncology Research Open access
Dirk Waldschmidt, Nam Gyu Im, Alexander Ioannis Damanakis, Thomas Schmidt, Albrecht Meyer zu Schwabedissen, Alexander Quaas, +13 more
0citations -
Follow-up of the Randomized ASAP Trial Shows No Survival Advantage for Patients with Poor Responsive or Relapsed AML Who Received Intensive Salvage Chemotherapy for Remission Induction Prior to Allogeneic Transplantation Compared to Immediate Allogeneic Transplantation
Matthias Stelljes, Jan Moritz Middeke, Gesine Bug, Eva-Maria Wagner Drouet, Lutz Peter Mueller, Christoph Schmid, +30 more
0citations
19 results